^
    BIOMARKER:

    MYC overexpression

    i
    Other names: MYC, bHLHe39, c-Myc, MYCC, V-myc avian myelocytomatosis viral oncogene homolog
    Entrez ID:
    4609
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    MYC overexpression
    Diffuse Large B Cell Lymphoma
    tisagenlecleucel-T
    Resistant: C3 – Early Trials
    MYC overexpression
    Mediastinal B Cell Lymphoma
    lisocabtagene maraleucel
    Resistant: C3 – Early Trials
    MYC overexpression
    Diffuse Large B Cell Lymphoma
    azacitidine oral
    Sensitive: C3 – Early Trials
    MYC overexpression
    Cervical Cancer
    GS-626510
    Sensitive: D – Preclinical
    MYC overexpression
    Mantle Cell Lymphoma
    TG-1701
    Sensitive: D – Preclinical
    MYC overexpression
    Multiple Myeloma
    bortezomib
    Resistant: D – Preclinical
    MYC overexpression
    Thyroid Gland Carcinoma
    MLN8237
    Sensitive: D – Preclinical
    MYC overexpression
    Diffuse Large B Cell Lymphoma
    INCB57643
    Sensitive: D – Preclinical
    MYC overexpression
    Mantle Cell Lymphoma
    venetoclax
    Sensitive: D – Preclinical
    MYC overexpression
    Gastric Cancer
    WB100
    Sensitive: D – Preclinical
    MYC overexpression
    Pancreatic Ductal Adenocarcinoma
    WB100
    Sensitive: D – Preclinical
    MYC overexpression
    AML
    WB100
    Sensitive: D – Preclinical
    MYC overexpression
    NSCLC
    MRT-2359
    Sensitive: D – Preclinical
    MYC overexpression
    NSCLC
    ROS1 inhibitor
    Resistant: D – Preclinical
    MYC overexpression
    Lymphoma
    brusatol
    Sensitive: D – Preclinical